Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.
D000818:Animals; D000831:Animals, Newborn; D000951:Antigens, Neoplasm; D000956:Antigens, Viral / Q000032:analysis; D000961:Antilymphocyte Serum; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002462:Cell Membrane / Q000276:immunology; D002999:Clone Cells; D003601:Cytotoxicity Tests, Immunologic; D006649:Histocompatibility Antigens / Q000032:analysis; D007165:Immunosuppression Therapy; D008545:Melanoma / Q000276:immunology* / Q000382:microbiology; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology / Q000382:microbiology; D012190:Retroviridae / Q000276:immunology; D014184:Transplantation, Homologous; D014779:Virus Replication / Q000187:drug effects
D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D000961:Antilymphocyte Serum; D006649:Histocompatibility Antigens; D001973:Bromodeoxyuridine